Dossier is submitted in reference member state. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.  

Sumatriptane is classified as a nervous system medicine, according ATC index.

Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

• 3rd Annual Biosimilars conference (24/11/2008)
• Croatia - Pharmaceuticals and Biotechnology (18/10/2008)
• Leading Drug Delivery Companies and Technologies (14/10/2008)

• Sertraline (10/07/2006)
• Salbutamol HFA (10/07/2006)
• Perinodopril (10/07/2006)
• Pamidronate (10/07/2006)
• Paclitaxel (10/07/2006)
• Oxaliplatin (10/07/2006)
• Omeprazole, capsules (10/07/2006)
• Misoprostol (10/07/2006)
• Mifepristone (10/07/2006)